Alembic Pharma’s JV receives EIR from USFDA for facility at Karkhadi

18 Dec 2019 Evaluate

Aleor Dermaceuticals (Aleor), a 60:40 Joint Venture (JV) between Alembic Pharmaceuticals (Alembic) and Orbicular Pharmaceutical Technologies (Orbicular), has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for the inspection carried out by them at Aleor's formulation facility at Karakhadi, Gujarat, India during the period from September 16, 2019 to September 20, 2019.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

871.10 -46.10 (-5.03%)
04-Jun-2024 14:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1434.75
Dr. Reddys Lab 5712.75
Cipla 1455.75
Zydus Lifesciences 1004.45
Lupin 1578.80
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.